Related Experiment Video
Updated: Apr 24, 2026

Electroporation of Mycobacteria
Published on: May 23, 2008
Structure of Mycobacterium smegmatis Eis in complex with paromomycin
Kyoung Hoon Kim1, Doo Ri An1, Hye Jin Yoon1
1Department of Chemistry, College of Natural Sciences, Seoul National University, Seoul 151-742, Republic of Korea.
Abstract:
The Rv2416c gene of Mycobacterium tuberculosis (Mtb) encodes the enhanced intracellular survival (Eis) protein that enhances intracellular survival of the pathogen in host macrophages during infection. The Mtb Eis protein is released into the cytoplasm of the phagocyte during intracellular infection and modulates the host immune response. It also contributes to drug resistance by acetylating multiple amine groups of aminoglycosides. Interestingly, the nonpathogenic M. smegmatis (Msm) contains a homologous eis gene (MSMEG_3513). The overall structures of Mtb Eis and Msm Eis are highly similar to each other, reflecting the high level (58%) of amino-acid sequence identity between them. Both Mtb Eis and Msm Eis are active as aminoglycoside acetyltransferases, while only Mtb Eis functions as an N(ℇ)-acetyltransferase to acetylate Lys55 of dual-specificity protein phosphatase 16 (DUSP16)/mitogen-activated protein kinase phosphatase 7 (MKP-7), leading to the suppression of host immune responses. Here, the crystal structure of Msm Eis in the paromomycin-bound form is reported, revealing detailed interactions between an aminoglycoside antibiotic and Msm Eis. The crystal structure of Msm Eis in the paromomycin-bound form has been determined at 3.3 Å resolution. This work provides potentially useful information for structure-guided discovery of Eis inhibitors as a novel antituberculosis drug against drug-resistant Mtb.
Insights
The Mycobacterium tuberculosis enhanced intracellular survival (Eis) protein aids pathogen survival and drug resistance. Determining the structure of M. smegmatis Eis provides insights for developing new tuberculosis drugs.
Area of Science:
- Microbiology
- Structural Biology
- Drug Discovery
Background:
- The enhanced intracellular survival (Eis) protein from Mycobacterium tuberculosis (Mtb) is crucial for pathogen survival within host macrophages and contributes to aminoglycoside antibiotic resistance.
- Mtb Eis modulates host immune responses and shares structural similarity with the homologous protein in nonpathogenic M. smegmatis (Msm).
Purpose of the Study:
- To elucidate the structural basis of aminoglycoside binding and acetylation by Msm Eis.
- To provide insights for the structure-guided development of novel antituberculosis agents targeting Eis.
Main Methods:
- Crystallization of M. smegmatis Eis (Msm Eis) in complex with the aminoglycoside antibiotic paromomycin.
- Determination of the Msm Eis-paromomycin complex structure at 3.3 Å resolution.
Main Results:
- The crystal structure reveals detailed molecular interactions between Msm Eis and paromomycin.
- Both Mtb Eis and Msm Eis exhibit aminoglycoside acetyltransferase activity.
- Only Mtb Eis possesses N(ℇ)-acetyltransferase activity, suppressing host immune responses via DUSP16/MKP-7 acetylation.
Conclusions:
- The determined structure of Msm Eis provides a valuable template for understanding aminoglycoside interactions.
- This structural information can guide the design of inhibitors targeting Eis for combating drug-resistant tuberculosis.
Related Concept Videos
Inhibitors of Bacterial Protein Synthesis
Bacterial Phylum Actinobacteria
Cytoskeletal Proteins in Bacteria

